semaglutide 7.2 mg clinical trial 7·2 was modestly superior to placebo and 2·4 mg (#wegovy) for #WeightLoss in adults with obesity, while retaining a favourable risk–benefit profile. We recently had the lead author on the Once-weekly semaglutide 7·2 mg in

Andrews RR, Anderson KR, Fry JL

How long does it last in the fridge

Nat Rev Rheumatol 21 , 671683 (2025)

It was found that in the first 10 years of GLP-1 therapeutics, the use of these medications in patients with type 2 diabetes mellitus and obesity is growing

#Semaglutide #DiabetesIndia #HealthcareLeadership #TransformingDiabetesCare #PharmaceuticalInnovation #DiabetesManagement #HealthcareIndia To view or add a comment, sign in From the latest JACC HTN Focus Issue: among individuals with uncontrolled hypertension, monthly tonlamarsen administration was more effective at lowering plasma angiotensinogen compared with a single tonlamarsen dose, but without additional BP reduction To view or add a comment, sign in Exciting advancement in the field of weight management